Advertisement

Topics

BiondVax Pharmaceuticals Company Profile

22:55 EDT 25th September 2018 | BioPortfolio


News Articles [337 Associated News Articles listed on BioPortfolio]

BiondVax Pharmaceuticals Ltd: Wayne Rudolph explains their focus on development of a Universal Influenza vaccine.

In this episode of PharmaTelevision News Review, filmed at BIO 2011, Fintan Walton talks to Wayne Rudolph, Vice President of Corporate Development of BiondVax Pharmaceuticals Ltd.

BiondVax enrols first patient in Phase lll trial of M-001

BiondVax Pharmaceuticals has enrolled the first patient in a Phase lll trial to evaluate the safety and efficacy of M-001...Read More... The post BiondVax enrols first patient in Phase lll trial of M-...

BiondVax to Present at Universal Influenza Vaccines Conference

NESSZIONA, Israel, April 12, 2018/PRNewswire/ --  BiondVax Pharmaceuticals Ltd.(Nasdaq: BVXV), developer of the universal flu vaccine candidate M-001, reported Read more...

CRO Appointed To Conduct Trial Of Biondvax's Universal Flu Vaccine

NewsBiondVax Pharmaceuticals Ltd. developer of the Universal Flu Vaccine candidate M-001 has selected a CRO to conduct the Phase 3 Trial.

BiondVax expands manufacturing capabilities for universal flu vaccine

BiondVax moved into a new facility with an increased capacity of 40 million doses per year ahead of potential approval for its universal flu vaccine.

Universal flu vaccine developer BiondVax signs CRO to advance Ph III trial

BiondVax is working closely with a CRO to advance its universal flu vaccine candidate, which will be manufactured in-house and in collaboration with a CMO to support tech-transfer pending a successful...

BiondVax signs CRO to advance universal flu vaccine candidate to Ph III trials

BiondVax is working closely with a CRO to advance its universal flu vaccine candidate, which will be manufactured in-house at the companyâs Israel-based facility and in collaboration with a CMO to su...

BiondVax Enters Agreement with CRO

To conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [145 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Clinical Trials [224 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1329 Associated Companies listed on BioPortfolio]

BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd

BiondVax is a publicly traded (TASE: BNDX), advanced clinical stage biotech company dedicated to improving protection against influenza, with its lead product a universal influenza (flu) vaccine cal...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "BiondVax Pharmaceuticals" on BioPortfolio

We have published hundreds of BiondVax Pharmaceuticals news stories on BioPortfolio along with dozens of BiondVax Pharmaceuticals Clinical Trials and PubMed Articles about BiondVax Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BiondVax Pharmaceuticals Companies in our database. You can also find out about relevant BiondVax Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record